Cited by — IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite IER5L Facilitates the Progression of Hormone Receptor-Positive Breast Cancer by Inhibiting HSF1 Phosphorylation in Response to Bevacizumab.
No admitted local citation edges point to this work yet.
